Search

Last updated: Accelerated Hypertension
on June 13, 2013

Hyperosmolar Hyperglycaemic Non-Ketotic Coma (HONK)

Key facts:

Authors: Kate Outterside, Sailesh Sankar, Ateeq Syed
Top Tip: Compared to DKA, HONK tends to affects older patients and its mortality is high

Key Differential Diagnoses

  • DKA
  • Hyperglycaemia, and other causes hypernatraemia or reduced conscious level

Key Investigations

  • Glucose (BM)
  • FBC, ESR, CRP
  • U+E, LFT, Bone, Glucose, HbA1C ± Troponin T
  • ABG, BC
  • ECG, CXR
  • Urinalysis ± MSU

Key Treatment

  • IV + FLUIDS
  • INSULIN (ACTRAPID, 50 units in 50 mls N saline), start infusion at 0.1 units/kg/hr
  • SC ENOXAPARIN 40 mg od

Key Management Decision

  • ITU

Background

Introduction

  • Compared to DKA, HONK tends to affects older patients and its mortality is high
  • In 60% it is the first presentation of diabetes (usually Type 2)
  • Whereas only 10-20% of DKAs are first presentation of Type 1 (rest are patients known to have Type 1)
  • Fluid resuscitation should be gentler, even though the fluid deficit is usually higher. A CVP line should be considered
  • Sodium tends to be high. If the sodium is very high (>160), consider 0.45% saline (otherwise there is a risk of cerebral oedema due to over hydration)
  • Glucose can be very high (>40 vs 10-30 mmol/L in DKA) but a gentler insulin regime should be used

Definition

  • Condition characterised by severe hyperglycemia, hyperosmolarity (hypernatraemia) and dehydration in the absence of significant ketoacidosis

Aetiology

  • Type 2 DM (60% first presentation of Type 2 DM)
  • Elderly
  • Genetic/racial (more common in Black/Asian people)
  • Obesity

Precipitants

  • MI
  • Infection
  • CVA
  • Abdominal catastrophe (eg mesenteric ischaemia, acute pancreatitis)

Symptoms

  • Non-specific
  • Of precipitant
    Note: can present as CVA, for eg

Key Question

  • "Have you had an infection (or chest pain) recently?"

Signs

  • Dehydration
  • Reduced level of consciousness
  • Seizures

Investigation

Glucose level is a guide to severity (in contrast to DKA). Unlike DKA, subsequent insulin therapy is not always necessary. Indeed some patients do well on hypoglycaemic agents and diet, or diet alone

Blood

  • Glucose (BM); ± there is a separate Capillary Blood Strip for ketones, if the urinalysis is equivocal, and you are not sure whether HONK, or DKA
  • FBC, ESR, CRP
  • U+E, LFT, Bone, Glucose, HbA1C
    Note: BG = >40 mmol/L; ie can be very high; much higher than DKA (10-30 mmol/L)
  • ± Troponin T (if abnormal ECG)
  • BC, ABG; pH 7.35-7.45 (vs < 7.3 in DKA)
  • Serum bicarbonate > 15 (vs < 15 in DKA)
    Note: can be acidotic for non-DKA reasons; eg coexistent lactic acidosis; this worsens prognosis++

Other

  • Urinalysis: ketones 1+ or less
  • ± MSU (infection?)
  • ECG (silent MI?)
  • CXR (infection?)

Key investigations

  • ABG
  • Glucos(BM)
  • Osmolality
  • To establish a diagnosis:
    Glucose: >40 mmol/L; plasma osmolality >350 mOsmol/kg; bicarbonate > 15 mmol/L; ketonuria 1+ or less, reduced conscious level

Specialist investigation

  • Serum osmolality: increased osmolarity >350 mOsmol/kg
    Note: measure it or calculate it
     = 2([Na + K] + [Urea] + [ Glucose])

Differential diagnoses

  • DKA
  • Hyperglycaemia and causes hypernatraemia or reduced level of onsciousness

Treatment

Treatment (first line)

Drugs

  • INSULIN (ACTRAPID, 50 units in 50 mls N saline, start infusion at 0.1 units/kg/hr; see DKA
    Note: unlike DKA, subsequent insulin therapy not always necessary; may do well on hypoglycaemia agents and diet, or diet alone
  • SC ENOXAPARIN 40 mg od
  • ± BROAD SPECTRUM AB (according to local policy), if infected

Procedures

  • BM (hourly), lab bloods every 4h
  • NG tube, if drowsy (prevent aspiration)
  • IV (+ FLUIDS); fluid replacement on basis of clinical state and associated CV morbidity
    Note: if Na > 160 mmol/L, give 0.45% saline, otherwise there is a risk of cerebral oedema due to over hydration; the Na level can be artificially high, and appear to go up, as glucose falls
  • OXYGEN, if hypoxic on air

Key management decision

  • ITU/not

Treatment (second line)

Drugs

  • If cerebral oedema, IV MANNITOL 0.25-2 g over 30-60 mins (usually 100 mls 20%), if cerebral oedema; repeated 1-2x after 4-8 hrs

Procedures

  • If unwell, urinary catheter, CVP line (more useful than in DKA), arterial line

Prescribing issues

  • Watch for cerebral oedema, if have given a lot of IV fluids

Admit?

  • Yes

Bed plan

  • Medical admission ward
  • ± Endocrine
  • ± ITU

Referrals

Medical

  • Endocrine
  • ± ITU

Other

  • DM nurse (± community DM nurse)

The Rest

Watch for cerebral oedema, if over hydrate (especially if N Saline given too fast, and Na very high). If occurs, give mannitol/dexamethasone

Complications

  • Arterial/venous thromboses
  • Of infection
  • Cerebral oedema, due to over hydration (if give N Saline too fast, and Na very high; if occurs, give mannitol/dexamethasone)

Follow-up

  • Hospital DM nurse
  • ± Community DM nurse + GP

Prognosis

  • 50% mortality (vs 2-5 % in younger patients with DKA), partly because of the higher risk of arterial/venous thromboses
  • Worse if BG very high, or co-existent lactic acidosis

2° Prevention + Health promotion

  • Education
  • Seek help, if BG > 20 mmol/L
  • Or cannot give (or run out of) insulin or hypoglycaemic agents

Don't forget

  • If sodium is very high (>160), give 0.45% IV saline

Red flags

  • Reduced conscious level
  • Severe sepsis/shock
  • Severe acidosis (pH <7.1); ie HONK not cause
    Note: if so, manage on ITU

References

international guidelines US/ADA: Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy. A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Nathan DM et

national guidelines UK/DoH: National Service Framework for Diabetes: Standards, 2001

reviews Diagnosis and treatment of diabetic ketoacidosis and the hyperglycemic hyperosmolar state. Chiasson J-L et al. CMAJ; 168(7): 859–866, 2003 (pdf)

Type 2 diabetes: principles of pathogenesis and therapy. Stumvoll M et al. Lancet; 365: 1333–46, 2005 (pdf)

YHPO: Diabetes Key Facts, Supplement 2007 (pdf)

Endocrine emergencies. Savage MW et al. Postgrad Med J; 80: 506-515, 2004

Kitabchi AE et al, Endotext.com, 2008